§ 866.6020. Immunomagnetic circulating cancer cell selection and enumeration system.
116 words·~1 min read·
/us/cfr/t21/s§ 866.6020·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Identification. An immunomagnetic circulating cancer cell selection and enumeration system is a device that consists of biological probes, fluorochromes, and other reagents; preservation and preparation devices; and a semiautomated analytical instrument to select and count circulating cancer cells in a prepared sample of whole blood. This device is intended for adjunctive use in monitoring or predicting cancer disease progression, response to therapy, and for the detection of recurrent disease.
(b)Classification. Class II (special controls). The special control for this device is FDA's guidance document entitled “Class II Special Controls Guidance Document: Immunomagnetic Circulating Cancer Cell Selection and Enumeration System.” See § 866.1(e) for availability of this guidance document. [69 FR 26038, May 11, 2004]
Connections1 cite this
Cited by 1 section
register
Citation graph
cites case law
§ 866.6020
Immunomagnetic circulating cancer cell selection and enumeration system.
Fed. Reg.×1
Cites 0Cited by 1 across 1 source